Ignite Creation Date:
2025-12-24 @ 11:46 AM
Ignite Modification Date:
2026-04-07 @ 3:29 PM
Study NCT ID:
NCT07209761
Status:
RECRUITING
Last Update Posted:
2025-12-10
First Post:
2025-08-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pulmonary Tuberculosis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Pulmonary Tuberculosis | View |
| None | Quabodepistat | View |
| None | Bedaquiline | View |
| None | Pretomanid | View |
| None | Linezolid | View |
| None | Moxifloxacin | View |
| None | Fluoroquinolone-sensitive TB | View |
| None | Fluoroquinolone-resistant TB | View |
| None | Drug-resistant TB | View |
| None | Shortened TB treatment | View |